Onderneming Inotek Pharmaceuticals Corp Nasdaq
Aandelen
US45780V1026
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- | - |
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Gaurav D. Shah
CEO | Chief Executive Officer | 49 | 04-01-18 |
Kinnari Patel
PSD | President | 46 | 04-01-18 |
Chief Tech/Sci/R&D Officer | 60 | 01-01-16 | |
Mayo Pujols
CTO | Chief Tech/Sci/R&D Officer | 55 | 27-07-22 |
David Southwell
BRD | Director/Board Member | 63 | 01-08-14 |
Brooks Rahmer
IRC | Investor Relations Contact | - | - |
Mark White
PRN | Corporate Officer/Principal | 57 | 04-04-23 |
Carlos Martin
PRN | Corporate Officer/Principal | - | - |
Isabel Carmona
HRO | Human Resources Officer | - | 07-09-21 |
Gayatri R. Rao
PRN | Corporate Officer/Principal | - | 01-05-18 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Pedro Granadillo
BRD | Director/Board Member | 77 | 04-01-18 |
Carsten Boess
BRD | Director/Board Member | 57 | 01-01-16 |
David Southwell
BRD | Director/Board Member | 63 | 01-08-14 |
Rod Wong
CHM | Chairman | 47 | 01-01-18 |
Director/Board Member | 47 | 01-01-18 | |
Gotham Makker
BRD | Director/Board Member | 50 | 04-01-18 |
Fady Malik
BRD | Director/Board Member | 59 | 10-03-22 |
Director/Board Member | 63 | 20-04-20 | |
Gaurav D. Shah
CEO | Chief Executive Officer | 49 | 04-01-18 |
R. Woods
BRD | Director/Board Member | 57 | 12/12 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 90 782 211 | 85 963 246 ( 94,69 %) | 0 | 94,69 % |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+5,33% | 111 mld. | |
+12,11% | 106 mld. | |
-12,56% | 22,24 mld. | |
-3,70% | 21,25 mld. | |
-6,03% | 18,97 mld. | |
-35,21% | 18,52 mld. | |
-10,86% | 16,81 mld. | |
+5,10% | 13,94 mld. | |
+37,57% | 12,54 mld. |
- Beurs
- Aandelen
- Koers RCKT
- Koers
- Onderneming Inotek Pharmaceuticals Corp